Design of the Randomized, Placebo ‐Controlled Evolocumab for Early Reduction of LDL‐Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS) Trial

This article is protected by copyright. All rights reserved.

Source: Clinical Cardiology - November 12, 2018 Category: Cardiology Authors: Konstantinos C. Koskinas, Stephan Windecker, Aliki Buhayer, Baris Gencer, Giovanni Pedrazzini, Christian Mueller, Stephan Cook, Olivier Muller, Christian M. Matter, Lorenz R äber, Dik Heg, François Mach, on behalf of the EVOPACS investigator Tags: TRIAL DESIGNS Source Type: research